Oral Presentations: Basic Sciences II.
Styevkóné Dinnyés, Andrea
Department of Physiology, Semmelweis University School of Medicine and MTA-SE „Lendület” Lymphatic Physiology Research Group, Budapest, Hungary
0614591500 x60454
dinnyes.andrea@med.semmelweis-univ.hu
Organ specific induction of lymphatic growth with nanoparticle-encapsulated nucleoside-modified VEGFC mRNA (VEGFC mRNA-LNP) complexes in vivo
Andrea Styevkóné Dinnyés1, Dániel Szőke1, Norbert Pardi2, Kitti Ajtay1, Drew Weissman2, Zoltán Jakus1
1 Department of Physiology, Semmelweis University School of Medicine and MTA-SE „Lendület” Lymphatic Physiology Research Group, Budapest, Hungary
2 University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA
molecular sciences
Oral Presentations: Basic Sciences II.
Doctoral School of Molecular Medicine
Cellular and Molecular Physiology
Zoltán Jakus MD, PhD
jakus.zoltan@med.semmelweis-univ.hu
Introduction: Lack or malfunction of lymphatics leads to the development of primary or secondary lymphedema. Currently, there is no efficient therapeutic approach for restoring lymphatic function in these diseases.
Aims: We aimed to develop a novel nanoparticle-encapsulated nucleoside-modified VEGFC mRNA complex (VEGFC mRNA-LNP) based system to induce lymphatic growth in vivo.
Methods: In our experiments purified nucleoside-modified mRNA (full-length VEGFC, GFP and poly(C) mRNA) were encapsulated into lipid nanoparticles. To characterize the system cell lines were transfected with mRNA-LNP complexes in vitro, and protein expression levels were monitored. Wild type and lymphatic reporter animals were injected with mRNA-LNPs locally or systemically, and lymphatic growth was assessed.
Results: We found that GFP and VEGFC mRNA-LNP complex transfection results in protein expression in cell lines in vitro. After injecting GFP mRNA-LNP complexes, significant increase of fluorescent signal was detected in isolated organs in vivo. Furthermore, we detected increased lymphatic growth after organ specific VEGFC mRNA-LNP treatment of the skin, diaphragm and skeletal muscle etc. with significant increase in the length, diameter and branch points of the lymphatic vessels.
Conclusions: Our results indicate that the mRNA-LNP system is an effective approach to trigger protein expression in vitro and in vivo. Furthermore, expression of VEGFC mRNA-LNP complexes is an efficient tool to induce lymphatic growth, which is a novel gain of function model to assess the organ specific physiological and pathophysiological roles of the lymphatic system. In addition, the system may provide the basis for the development of a new therapeutic tool for the treatment of lymphedemas in the future.
Szabad
nem rendelkezett róla
1323
Andrea Styevkóné Dinnyés1, Dániel Szőke1, Norbert Pardi2, Kitti Ajtay1, Drew Weissman2, Zoltán Jakus1
1 Department of Physiology, Semmelweis University School of Medicine and MTA-SE „Lendület” Lymphatic Physiology Research Group, Budapest, Hungary
2 University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA